Key result
Revascularization strategies such as CABG and PCI provide guidance for clinical decision making in patients with ischemic cardiomyopathy, though areas of uncertainty remain.
This review discusses the evolving role of CABG and PCI in managing patients with ischemic cardiomyopathy, highlighting current guidance and areas of uncertainty.
oronary artery disease (CAD) is the most common cause of left ventricular dysfunction and heart failure (ischemic cardiomyopathy [ICM]). The increasing sophistication of coronary artery bypass grafting (CABG) and percutaneous intervention (PCI) raises important questions about the appropriate role of revascularization, CABG, or PCI in treating patients with ICM. Understandings now in hand provide guidance regarding clinical decision making, underscore areas of uncertainty, and point to next steps in the quest to better understand the role of revascularization in these patients.
No takes yet. Share an insight, caveat, or question.
Domanski et al. (2018) conducted a review in Left ventricular dysfunction and severe coronary artery disease (ischemic cardiomyopathy). Revascularization (CABG or PCI) was evaluated. Revascularization strategies such as CABG and PCI provide guidance for clinical decision making in patients with ischemic cardiomyopathy, though areas of uncertainty remain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: